Abstract
Transcutol® or diethylene glycol monoethyl ether is a liquid which has a long history of use in cosmetic and over-the-counter topically applied products. Transcutol® has been applied in several commercial preparations and is used in many studies as the main ingredient of formulations. It has been used in formulations as a co-surfactant and a penetration enhancer. It is frequently utilized in topical formulations (dermal drug delivery systems), transdermal delivery systems, and ocular and also intranasal delivery systems. It is also used as an ingredient in nanoemulsions, sunless tanning products, and in a wide range of hair-coloring products which are rinse-off products. This solvent will be a key component of many cosmetic products as well as dermatics in foreseeable future. In this chapter, some of the most important physicochemical properties of Transcutol® will be reviewed, as well as its application, pharmacology, and biomedical effects and toxicity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Amrish C, Kumar SP (2009) Transdermaldelivery of ketorolac. Yakugaku Zasshi 129(3):373–379
Artusi M, Nicoli S, Colombo P, Bettini R, Sacchi A, Santi P (2004) Effect of chemical enhancers and iontophoresis on thiocolchicoside permeation across rabbit and human skin in vitro. J Pharm Sci 93:2431–2438
Baboota S, Shakeel F, Ahuja A, Ali J (2007) Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib. Acta Pharm 57:315–332
Barakat N, Fouad E, Elmedany A (2011) Formulation design of indomethacin-loaded nanoemulsion for transdermal delivery. Pharm Anal Acta S2:1–8
Baroli B, Lopez-Quintela MA, Delgado-Charro MB, Fadda AM, Blanco- Mendez J (2000) Microemulsions for topical delivery of 8-methoxsalen. J Control Release 69:209–218
Barry BW (1983) Dermatological formulation: percutaneous absorption. Marcel Dekker, New York
Barry BW (1987) Mode of action of penetration enhancers in human skin. J Control Release 6:85–97
Bialik W, Walters KA, Brain KR, Hadgraft J (1993) Some factors affecting the in vitro penetration of ibuprofen through human skin. Int J Pharm 92:219–223
Budden R, Kühl G, Bahlsen J (1979) Experiments on the toxic, sedative and muscle relaxant potency of various drug solvents in mice. Pharmacol Ther 5:467–474
Cázares-Delgadillo J, Naik A, Kalia YN, Quintanar-Guerrero D, Ganem-Quintanar A (2005) Skin permeation enhancement by sucrose esters: a pH-dependent phenomenon. Int J Pharm 297:204–212
Censi R, Martena V, Hoti E, Malaj L, Di Martino P (2011) Permeation and skin retention of quercetin from microemulsions containing Transcutol® P. Drug Dev Ind Pharm 38(9):1128–1133
Chessa M, Caddeo C, Valenti D, Manconi M, Sinico C, Fadda AM (2011) Effect of penetration enhancer containing vesicles on the percutaneous delivery of quercetin through new born pig skin. Pharmaceutics 3:497–509
Delongeas JL, Conchard GVD, Beamonte A, Bertheux H, Spire C, Maisonneuve C et al (2010) Assessment of Labrasol_/Labrafil_/Transcutol_ (4/4/2, v/v/v) as a non-clinical vehicle for poorly water-soluble compounds after 4-week oral toxicity study in Wistar rats. Regul Toxicol Pharmacol 57:284–290
Elshafeey AH, Hamza YE, Amin SY, Akhlaghi F, Zia H (2011) Enhanced bioavailability of fenoterol transdermal systems in rabbits. J Bioequiv Availab 3(5):97–100
Escobar-Chávez JJ, Quintanar-Guerrero D, Ganem-Quintanar A (2005) In vivo skin permeation of sodium naproxen formulated in pluronic F-127 gels: effect of Azone and Transcutol. Drug Dev Ind Pharm 31(4–5):447–454
Escribano E, Calpena AC, Queralt J, Obach R, Doménech J (2003) Assessment of diclofenac permeation with different formulations: anti-inflammatory study of a selected formula. Eur J Pharm Sci 19(4):203–210
Fini A, Bergamante V, Ceschel GC, Ronchi C, De Moraes CAF (2008) Control of transdermal permeation of hydrocortisone acetate from hydrophilic and lipophilic formulations. AAPS Pharm Sci Tech 9(3):762–768
Gannu R, Vishnu YV, Kishan V, Rao YM (2008) In vitro permeation of carvedilol through porcine skin: effect of vehicles and penetration enhancers. PDA J Pharm Sci Technol 62(4):256–263
Goyali U, Arora R, Aggarwal G (2012) Formulation design and evaluation of a self-microemulsifying drug delivery system of lovastatin. Acta Pharm 62:357–370
Harrison JE, Watkinson AC, Green DM, Hadgraft J, Brain K (1996) The relative effect of Azone and Transcutol on permeant diffusivity and solubility in human stratum corneum. Pharm Res 13(4):542–546
Hathout RM, Woodman TJ, Mansour S, Mortada ND, Geneidi AS, Guy RH (2010) Microemulsion formulations for the transdermal delivery of testosterone. Eur J Pharm Sci 40(3):188–196
Jain R, Patravale VB (2009) Development and evaluation of nitrendipine nanoemulsion for intranasal delivery. J Biomed Nanotechnol 5(1):62–68
Javadzadeh Y, Hamishehkar H (2011) Enhancing percutaneous delivery of methotrexate using different types of surfactants. Colloids Surf B Biointerfaces 82:422–426
Javadzadeh Y, Shokri J, Hallaj-Nezhadi S, Hamishehkar H, Nokhodchi A (2010) Enhancement of percutaneous absorption of Finasteride by cosolvents, cosurfactant and surfactants. Pharm Dev Technol 15(6):619–625
Javadzadeh Y, Siahi MR, Asnaashari S, Nokhodchi A (2007) Liquisolid technique as a tool for enhancement of poorly water-soluble drugs and evaluation of their physicochemical properties. Acta Pharm 57:99–109
Li C, Liu C, Liu J, Fang L (2011) Correlation between rheological properties, in vitro release, and percutaneous permeation of tetrahydropalmatine. AAPS PharmSciTech 12(3):1002–1009
Liu Z, Li J, Nie S, Guo H, Pan W (2006) Effects of Transcutol P on the corneal permeability of drugs and evaluation of its ocular irritation of rabbit eyes. J Pharm Pharmacol 58(1):45–50
Manconi M, Caddeo C, Sinico C, Valenti D, Mostallino MC, Biggio G, Fadda AM (2011a) Ex vivo skin delivery of diclofenac by transcutol containing liposomes and suggested mechanism of vesicle–skin interaction. Eur J Pharm Biopharm 78:27–35
Manconi M, Sinico C, Caddeo C, Vila AO, Valenti D, Fadda AM (2011b) Penetration enhancer containing vesicles as carriers for dermal delivery of tretinoin. Int J Pharm 412:37–46
Mandal S, Mandal SS (2011) Microemulsion drug delivery system: a platform for improving dissolution rate of poorly water soluble drug. Int J Pharm Sci Nanotech 3(4):1214–1219
Mura P, Faucci MT, Bramanti G, Corti P (2000) Evaluation of transcutol as a clonazepam transdermal permeation enhancer from hydrophilic gel formulations. Eur J Pharm Sci 9(4):365–372
Mura S, Manconi M, Sinico C, Valenti D, Fadda AM (2009) Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil. Int J Pharm 380:72–79
Mura S, Manconi M, Valenti D, Sinico C, Vila AO, Fadda AM (2011) Transcutol containing vesicles for topical delivery of minoxidil. J Drug Target 19(3):189–196
Osborne DW (2011) Diethylene glycol monoethyl ether: an emerging solvent in topical dermatology products. J Cosmet Dermatol 10:324–329
Ritschel WA, Hussain AS (1988) Influence of selected solvents on penetration of griseofulvin in rat skin, in vitro. Pharm Ind 50:483–486
Senyiğit T, Padula C, Ozer O, Santi P (2009) Different approaches for improving skin accumulation of topical corticosteroids. Int J Pharm 380(1–2):155–160
Shishu, Rajan S, Kamalpreet (2009) Development of novel microemulsion-based topical formulations of acyclovir for the treatment of cutaneous herpetic infections. AAPS PharmSciTech 10(2):559–562
Shokri J, Azarmi S, Fasihi Z, Hallaj-Nezhadi S, Nokhodchi A, Javadzadeh Y (2012) Effects of various penetration enhancers on percutaneous absorption of piroxicam from emulgels. Res Pharm Sci 7(4):225–234
Sinha VR, Kaur MP (2000) Permeation enhancers for transdermal drug delivery. Drug DevInd Pharm 26(11):1131–1140
Singh PB, Choudhury PK (2007) Penetration enhancers for transdermal drug delivery of systemic agents. J Pharm Res 6:44–50
Solanki SS, Sarkar B, Dhanwani RK (2012) Microemulsion drug delivery system: for bioavailability enhancement of ampelopsin. ISRN Pharm 2012:1–4
Touitou E, Levi-Schaffer F, Dayan N, Alhaique F, Riccieri F (1994) Modulation of caffeine skin delivery by carrier design: liposomes versus permeation enhancers. Int J Pharm 103:131–136
Watkinson AC, Hadgraft J, Bye A (1991) Aspects of the transdermal delivery of prostaglandins. Int J Pharm 74:229–236
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Javadzadeh, Y., Adibkia, K., Hamishekar, H. (2015). Transcutol® (Diethylene Glycol Monoethyl Ether): A Potential Penetration Enhancer. In: Dragicevic, N., Maibach, H. (eds) Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-47039-8_12
Download citation
DOI: https://doi.org/10.1007/978-3-662-47039-8_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-47038-1
Online ISBN: 978-3-662-47039-8
eBook Packages: MedicineMedicine (R0)